Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on June 19, 2026

12 hours ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

13 hours ago

Invitation à assister à l'assemblée générale extraordinaire des actionnaires de la Société qui se tiendra le 9 juillet 2026  

Indeterminate GlobeNewswire

13 hours ago

Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026

Indeterminate GlobeNewswire

13 hours ago

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

14 hours ago

Dr. Austin Harris, MD Announces NAD+ IV Infusion Therapy Availability at NeuroRelief for Cellular Health and Cognitive Wellness Support in 2026

Indeterminate GlobeNewswire

14 hours ago

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

14 hours ago

Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders

Indeterminate GlobeNewswire

16 hours ago

Boston Dental Named The Best Dentist in Boston

Indeterminate GlobeNewswire

17 hours ago

More Adults Are Turning to Better Sleep Hygiene in a Phone-Free Bedtime Environment

Indeterminate GlobeNewswire

18 hours ago

Comprehensive Healthcare opens Columbia Valley Center for Recovery, the Tri-Cities' first inpatient behavioral health treatment and recovery facility

Indeterminate GlobeNewswire

Jun. 19, 2026

FDA Approves Labeled Strength Update of TWIRLA® (levonorgestrel/ethinyl estradiol) Birth Control Patch

Indeterminate GlobeNewswire

Jun. 19, 2026

Protein Labeling Market to Reach New Heights by 2031, Driven by Surge in Biomedical Research Funding

Indeterminate GlobeNewswire

Jun. 19, 2026

Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam

Indeterminate GlobeNewswire

Jun. 19, 2026

uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy

Indeterminate GlobeNewswire

Jun. 19, 2026

Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma

Indeterminate GlobeNewswire

Jun. 19, 2026

Communiqué de presse : Sarclisa de Sanofi en formulation sous-cutanée approuvé au Japon pour les patients atteints de myélome multiple

Indeterminate GlobeNewswire

Jun. 19, 2026

Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026

Indeterminate GlobeNewswire

Jun. 19, 2026

Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026

Indeterminate GlobeNewswire

Jun. 19, 2026

The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share

Indeterminate GlobeNewswire

Jun. 19, 2026

Arletta Pharma Solutions Appoints Steve van Os, MD, as Chief Medical Officer

Indeterminate GlobeNewswire